美国痛风患者严重感染的发病率、时间趋势与结局:一项全国性研究
该研究基于美国全国住院样本(1998-2016)分析痛风患者因严重感染住院的流行病学。痛风患者严重感染住院占所有痛风住院的11%,比例从1998-2000年的8.9%升至2015-2016年的14.5%。最常见感染由肺炎转为脓毒症,脓毒症和机会性感染患者住院费用和时长更高,且多种因素与更高的医疗利用和死亡率相关。
要点
- 痛风患者严重感染住院比例从8.9%增至14.5%,脓毒症成为最常见感染。
- 脓毒症和机会性感染患者住院费用与时长高于尿路感染、肺炎和皮肤软组织感染。
- 高龄、Medicaid保险、高合并症指数、黑人种族等与更高的医疗利用和死亡率相关。
核心结论
- 痛风患者严重感染住院率呈上升趋势,尤其是脓毒症和肺炎,需针对相关因素开发有效干预以改善结局并减轻负担。
研究设计与样本
- 基于美国全国住院样本(1998-2016)的回顾性研究,纳入因肺炎、脓毒症/菌血症、尿路感染、皮肤软组织感染或机会性感染住院的痛风患者,分析医疗利用和死亡相关因素。
主要发现
- 严重感染住院占痛风所有住院的11%,1998-2000年为8.9%,2015-2016年为14.5%。
- 与无痛风患者相比,痛风合并严重感染患者更年长(中位年龄65 vs 74岁),Charlson-Deyo合并症指数≥2者更多(42% vs 65%),女性和非白人比例更低(女性53% vs 35%;非白人40% vs 35%)。
- 1998-2000年最常见感染为肺炎(52%),2015-2016年最常见为脓毒症(52%)。
- 2015-2016年脓毒症和机会性感染患者的中位住院费用($41,000-$42,000)和住院时长(5.1-5.5天)高于尿路感染、肺炎或皮肤软组织感染患者($15,000-$17,000;3.0-3.9天)。
- 与脓毒症患者相比,尿路感染、皮肤软组织感染和肺炎患者的医疗利用和院内死亡的多变量调整比值比显著更低,机会性感染患者的非家庭出院或院内死亡也更低。
临床怎么用
- 临床应关注痛风患者严重感染风险上升趋势,尤其脓毒症和肺炎,并识别高龄、合并症多、Medicaid保险等高风险因素以优化管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the epidemiology of serious infections in patients hospitalized with gout. METHODS: We identified patients with gout hospitalized with a primary diagnosis of pneumonia, sepsis/bacteremia, urinary tract infection (UTI), skin and soft tissue infections (SSTIs), or opportunistic infections (OIs) in a US National Inpatient Sample from 1998 to 2016 and examined factors associated with utilization and mortality. RESULTS: We noted 1,140,085 hospitalizations of patients with serious infections and gout (11% of all hospitalizations of patients with gout; 1998-2000 [8.9%], 2015-2016 [14.5%]). Compared to patients without gout, patients with gout hospitalized with serious infections were older (median age 65 versus 74 years), more of them had a Charlson-Deyo comorbidity index score ≥2 (42% versus 65%), and fewer were female (53% versus 35%) or non-White (40% versus 35%), respectively. The most common infection was pneumonia (52%) in 1998-2000 and sepsis (52%) in 2015-2016. Median hospital charges and hospital stays were higher for patients with sepsis and OIs in 2015-2016 ($41,000-$42,000; 5.1-5.5 days) versus those with UTI, pneumonia, or SSTIs ($15,000-$17,000; 3.0-3.9 days). Compared to patients with sepsis, the multivariable-adjusted odds of health care utilization and in-hospital mortality were significantly lower for patients with UTI, SSTIs, and pneumonia, and non-home discharge or in-hospital mortality were lower in patients with OIs. Among patients hospitalized with infections, older age, Medicaid coverage, a higher Charlson-Deyo comorbidity index score, Black race, and Northeast and nonrural hospital location were associated with significantly higher health care utilization and mortality, while female sex, Medicare insurance, and lower income were associated with higher utilization. CONCLUSION: Given an increasing rate of serious infections, especially sepsis and pneumonia, in individuals with gout, development of effective interventions targeting factors associated with health care utilization and mortality will improve outcomes and reduce burden.
引用
- Singh JA, Cleveland JD. Serious Infections in Patients With Gout in the US: A National Study of Incidence, Time Trends, and Outcomes. Arthritis Care Res (Hoboken). 2021. PMID: 32248660. doi:10.1002/acr.24201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。